2007TumoriRequires access

Expression and clinicopathological significance of several kinds of multidrug-resistance related factors in lung carcinoma

Yang Zhi-hui

Open publisher page 0 citations

Abstract

Objective:To investigate the expression and clinicopathological significance of several kinds of multidrug-resistance related factors in primary lung carcinoma.Methods:One hundred and thirty three cases of lung carcinoma tissues confirmed by pathological examination after surgery were included in the study and 15 cases of pericancerous tissues(5-cm apart from tumor) were selected as control.The expressions of P-gp(P-glycoprotein),multidrug resistance-associated protein(MRP),lung resistance-related protein(LRP),p53,and c-erbB2 protein in paraffin-embedded tissues were detected by immunohistochemistry.Results:(1) The positive rates of P-gp,MRP,LRP,p53 and c-erbB2 in tumor tissues were 72.2%(96/133),40.5%(51/126),54.1%(72/126),59.4%(79/126),and 45.9%(61/133),respectively,which were significantly higher than that in normal controls(P0.05) except for the P-gp(P0.05).The expression of p53 correlated with P-gp and MRP(r=0.179 and 0.185,P=0.039 and 0.041).There were significant correlation between P-gp and LRP(r=0.264,P=0.002)as well as LRP and MRP(r=0.309,P0.001).The expression of c-erbB-2 was associated with that of MRP,LRP,and p53(r=0.350,0.421,0.541,and 0.354,respectively;P0.001).(2) There was significant difference among the different pathologic types in P-gp,MRP,LRP,and c-erbB-2 expression(P0.001).The difference in P-gp expression was significant in lung squamous carcinoma at different differentiation degree(P=0.049).(3) According to pathological classification/sub-classification: ①The expression levels of LRP and c-erbB-2 were higher in the panel of neuroendocrine carcinoma than that in the panel of non neuroendocrine carcinoma(P=0.005 and 0.041,respectively);②There was no significant difference in the expression of MDR-related factors between the panel of bronchioloalveolar carcinoma and other types of adenocarcinoma.Conclusion:These multidrug-resistance relate factors play important roles in the intrinsic multidrug resistance of lung cancer in different degrees.They have some correlations between each other in the formation of multidurg resistance and the progression of lung cancer.

About this research paper

What this paper is about

Objective:To investigate the expression and clinicopathological significance of several kinds of multidrug-resistance related factors in primary lung carcinoma.Methods:One hundred and thirty three cases of lung carcinoma tissues confirmed by pathological examination after surgery were included in the study and 15 cases of pericancerous tissues(5-cm apart from tumor) were selected as control.The expressions of P-gp(P-glycoprotein),multidrug resistance-associated protein(MRP),lung resistance-related protein(LRP),p53,and c-erbB2 protein in paraffin-embedded tissues were detected by immunohistochemistry.Results:(1) The positive rates of P-gp,MRP,LRP,p53 and c-erbB2 in tumor tissues were 72.2%(96/133),40.5%(51/126),54.1%(72/126),59.4%(79/126),and 45.9%(61/133),respectively,which were significantly higher than that in normal controls(P0.05) except for the P-gp(P0.05).The expression of p53 correlated with P-gp and MRP(r=0.179 and 0.185,P=0.039 and 0.041).There were significant correlation between P-gp and LRP(r=0.264,P=0.002)as well as LRP and MRP(r=0.309,P0.001).The expression of c-erbB-2 was associated with that of MRP,LRP,and p53(r=0.350,0.421,0.541,and 0.354,respectively;P0.001).(2) There was significant difference among the different pathologic types in P-gp,MRP,LRP,and c-erbB-2 expression(P0.001).The difference in P-gp expression was significant in lung squamous carcinoma at different differentiation degree(P=0.049).(3) According to pathological classification/sub-classification: ①The expression levels of LRP and c-erbB-2 were higher in the panel of neuroendocrine carcinoma than that in the panel of non neuroendocrine carcinoma(P=0.005 and 0.041,respectively);②There was no significant difference in the expression of MDR-related factors between the panel of bronchioloalveolar carcinoma and other types of adenocarcinoma.Conclusion:These multidrug-resistance relate factors play important roles in the intrinsic multidrug resistance of lung cancer in different degrees.They have some correlations between each other in the formation of multidurg resistance and the progression of lung cancer.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To investigate the expression and clinicopathological significance of several kinds of multidrug-resistance related factors in primary lung carcinoma.Methods:One hundred and thirty three cases of lung carcinoma tissues confirmed by pathological examination after surgery were included in the study and 15 cases of pericancerous tissues(5-cm apart from tumor) were selected as control.The expressions of P-gp(P-glycoprotein),multidrug resistance-associated protein(MRP),lung resistance-related protein(LRP),p53,and c-erbB2 protein in paraffin-embedded tissues were detected by immunohistochemistry.Results:(1) The positive rates of P-gp,MRP,LRP,p53 and c-erbB2 in tumor tissues were 72.2%(96/133),40.5%(51/126),54.1%(72/126),59.4%(79/126),and 45.9%(61/133),respectively,which were significantly higher than that in normal controls(P0.05) except for the P-gp(P0.05).The expression of p53 correlated with P-gp and MRP(r=0.179 and 0.185,P=0.039 and 0.041).There were significant correlation between P-gp and LRP(r=0.264,P=0.002)as well as LRP and MRP(r=0.309,P0.001).The expression of c-erbB-2 was associated with that of MRP,LRP,and p53(r=0.350,0.421,0.541,and 0.354,respectively;P0.001).(2) There was significant difference among the different pathologic types in P-gp,MRP,LRP,and c-erbB-2 expression(P0.001).The difference in P-gp expression was significant in lung squamous carcinoma at different differentiation degree(P=0.049).(3) According to pathological classification/sub-classification: ①The expression levels of LRP and c-erbB-2 were higher in the panel of neuroendocrine carcinoma than that in the panel of non neuroendocrine carcinoma(P=0.005 and 0.041,respectively);②There was no significant difference in the expression of MDR-related factors between the panel of bronchioloalveolar carcinoma and other types of adenocarcinoma.Conclusion:These multidrug-resistance relate factors play important roles in the intrinsic multidrug resistance of lung cancer in different degrees.They have some correlations between each other in the formation of multidurg resistance and the progression of lung cancer.

Key concepts: Multiple drug resistance, Immunohistochemistry, P-glycoprotein, Lung, Carcinoma, Clinical significance, Pathological, Lung cancer

Related papers

Back to paper searchBrowse research topicsOriginal source
Expression and clinicopathological significance of several kinds of multidrug-resistance related factors in lung carcinoma — Research Paper | ScholarLens